个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

National Brain Tumour Registry of China (NBTRC) statistical report of primary brain tumours diagnosed in China in years 2019-2020

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE ◇ SSCI

作者：
Xiao Dan[1] ; Yan Changxiang[2] ; Li Deling[1,3,4] ; Xi Tianshu[1] ; Liu Xianzhi[5] ; Zhu Dan[6] ; Huang Guodong[7] ; Xu Jianguo[8] ; He Zhengwen[9] ; Wu Anhua[10] ; Ma Chiyuan[11] ; Long Jiang[12] ; Shu Kai[13] ; Ji Hongming[14] ; Wang Ning[15] ; Chen Gang[16] ; Yang Jiankai[17] ; Ma Hui[18] ; Li Zhiyong[19] ; Sun Xiaochuan[20] ; Qu Yan[21] ; Liu Zhixiong[22] ; Jiang Xiaofan[23] ; Tian Chunlei[24] ; Ni Shilei[25] ; Zhan Renya[26] ; Chen Liwen[27] ; Ge Ming[28] ; Wang Maode[29] ; Jiang Xiaobing[30] ; Guo Geng[31] ; Han Zhenmin[32] ; Zhang Chuan[33] ; Zhang Tingrong[34] ; Dou Changwu[35] ; Chu Liangzhao[36] ; Wang Pengcheng[37] ; Shao Junfei[38] ; Wu Xiyue[39] ; Yu Ju[40] ; Wang Yu[41] ; Wu Nan[42] ; Zhang Rui[43] ; Zhang Mingming[44] ; Hong Yong[45] ; Gao Jianzhong[46] ; Li Yunqian[47] ; Pan Yawen[48] ; Zhao Bing[49] ; Ji Nan[1,3,4] ; Shan Guangliang[50] ; Patel Chirag B[51] ; Jia Wang[1,3,4] ; Zhang Liwei[1,3,4,*1,*2,*3] ;
机构： [1]China National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing, China. [2]Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China. [3]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. [4]Beijing Neurosurgical Institute, Beijing, China. [5]Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. [6]Department of Neurosurgery, Guangdong 999 Brain Hospital, Guangzhou, China. [7]Department of Neurosurgery and Shenzhen Key Laboratory of Neurosurgery, Shenzhen University 1st Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen, China. [8]Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China. [9]Department of Neurosurgery, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China. [10]Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, China. [11]Department of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China. [12]Department of Neurosurgery, The First Affiliated Hospital of Kunming Medical University, Kunming, China. [13]Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. [14]Department of Neurosurgery, Shanxi Medical University Shanxi Provincial People's Hospital, Taiyuan, China. [15]Department of Neurosurgery, the First Affiliated Hospital of Harbin Medical University, Harbin, China. [16]Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, China. [17]Department of Neurosurgery, the Second Hospital of Hebei Medical University, Shijiazhuang, China. [18]Department of Neurosurgery, Ningxia Medical University General Hospital, Yinchuan, China. [19]Department of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, China. [20]Department of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. [21]Department of Neurosurgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China. [22]Department of Neurosurgery, Xiangya Hospital of Central South University, Changsha, China. [23]Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China. [24]Department of Neurosurgery, Institute of Neurosurgery, Yichang Central People's Hospital & The First Clinical Medical College of Three Gorges University, Yichang, China. [25]Department of Neurosurgery, Qilu Hospital and Institute of Brain and Brain-Inspired Science, Cheeloo College of Medicine, Shandong University, Jinan, China. [26]Department of Neurosurgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. [27]Department of Neurosurgery, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. [28]Department of Neurosurgery, National Center for Children's Health, Beijing Children's Hospital, Capital Medical University, Beijing, China. [29]Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. [30]Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. [31]Department of Neurosurgery, the First Hospital, Shanxi Medical University, Taiyuan, China. [32]Department of Neurosurgery, Affiliated Hospital of Chifeng University, Chifeng, China. [33]Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China. [34]Department of Neurosurgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China. [35]Department of Neurosurgery, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China. [36]Department of Neurosurgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, China. [37]Department of Neurosurgery, Hainan Provincial People's Hospital, Haikou, China. [38]Department of Neurosurgery, Wuxi People's Hospital of Nanjing Medical University, Wuxi, China. [39]Department of Neurosurgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China. [40]Department of Neurosurgery, the Second Affiliated Hospital of Soochow University, Suzhou, China. [41]Department of Neurosurgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. [42]Department of Neurosurgery, Chongqing Hospital Affiliated to University of Chinese Academy of Science/Chongqing General Hospital, Chongqing, China. [43]Department of Neurosurgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China. [44]Department of Neurosurgery, The Second Xiangya Hospital of Central South University, Changsha, China. [45]Department of Neurosurgery, Chengde Central Hospital, Chengde, China. [46]Department of Neurosurgery, First Hospital of Yulin, Yulin, China. [47]Department of Neurosurgery, First Hospital of Jilin University, Changchun, China. [48]Department of Neurosurgery, Lanzhou University Second Hospital, Lanzhou, China. [49]Department of Neurosurgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, China. [50]Department of Epidemiology and Statistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, China. [51]Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
出处：
DOI： 10.1016/j.lanwpc.2023.100715

关键词： Brain tumor Registry Distribution China

摘要：
The lack of a well-designed brain tumour registry with standardized pathological diagnoses in underdeveloped countries hinders the ability to compare epidemiologic data across the globe. The National Brain Tumour Registry of China (NBTRC), created in January 2018, is the first multi-hospital-based brain tumour registry in China. Patient data reported to the NBTRC in years 2019-2020 were assessed.Tumour pathology was based on the 2016 World Health Organization (WHO) classification of tumours of the central nervous system and ICD-O-3. The anatomical site was coded per the Surveillance, Epidemiology, and End Results (SEER) solid tumour module (version of July 2019). The cases were tabulated by histology and anatomical site. Categorical variables were reported as numbers (percentages). The distribution of tumours by age (0-14, 15-19, 20-39, 40-64, and 65+ years) was analysed.There were a total of 25,537 brain tumours, foremost among them meningioma (23.63%), followed by tumours of the pituitary (23.42%), and nerve sheath tumours (9.09%). Glioblastoma, the most common and lethal form of primary brain cancer in adults, represented 8.56% of all cases. Of note, 6.48% of the malignant tumours were located in the brain stem. The percentage of malignant brain tumours decreased with increasing age, 24.08% in adults (40+ years), 30.25% in young adults (20-39 years), 35.27% in adolescents (15-19 years), and 49.83% in children (0-14 years). Among the 2107 paediatric patients, the most common sites were ventricle (17.19%), brainstem (14.03%), pituitary and craniopharyngeal duct (13.4%), and cerebellum (12.3%), a distribution that differed from that of the entire cohort. The histology distribution was also unique in children, with glioblastoma much less incident compared to the whole cohort (3% vs. 8.47%, p < 0.01). 58.80% of all patients chose higher-level neurosurgical hospitals outside of their province of residence. The median in-hospital length of stay (LOS) for the various pathologies ranged from 11 to 19 days.The histological and anatomical site distribution of brain tumours in the NBTRC was statistically different in the subgroup of children (0-14 years). Patient choice of pursuing trans-provincial treatment was common and the in-hospital LOS was longer compared to that reported in similar European and American patient populations, which merits further attention.The National Key Research and Development Program of China (2015BAI12B04, 2013BAI09B03, 2014BAI04B01, and 2021YFF1201104) and Chinese National Natural Science Foundation of China (81971668).© 2023 Published by Elsevier Ltd.

基金：
The National Key Research and Development Program of China (2015BAI12B04, 2013BAI09B03, 2014BAI04B01, and 2021YFF1201104) and Chinese National Natural Science Foundation of China (81971668).
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类 | 1 区 医学
小类 | 1 区 卫生保健与服务 1 区 公共卫生、环境卫生与职业卫生
最新[2023]版：
大类 | 1 区 医学
小类 | 1 区 卫生保健与服务 1 区 公共卫生、环境卫生与职业卫生
JCR分区：
出版当年[2023]版：
Q1 HEALTH CARE SCIENCES & SERVICES Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
最新[2023]版：
Q1 HEALTH CARE SCIENCES & SERVICES Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

影响因子： 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者：
第一作者机构： [1]China National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing, China.
共同第一作者：
通讯作者：
通讯机构： [1]China National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing, China. [3]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. [4]Beijing Neurosurgical Institute, Beijing, China. [*1]China National Clinical Research Center for Neurological Diseases (NCRC-ND), Beijing, China [*2]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China [*3]Beijing Neurosurgical Institute, Beijing, China.
推荐引用方式(GB/T 7714)：
Xiao Dan,Yan Changxiang,Li Deling,et al.National Brain Tumour Registry of China (NBTRC) statistical report of primary brain tumours diagnosed in China in years 2019-2020[J].LANCET REGIONAL HEALTH-WESTERN PACIFIC.2023,34:doi:10.1016/j.lanwpc.2023.100715.
APA：
Xiao Dan,Yan Changxiang,Li Deling,Xi Tianshu,Liu Xianzhi...&Zhang Liwei.(2023).National Brain Tumour Registry of China (NBTRC) statistical report of primary brain tumours diagnosed in China in years 2019-2020.LANCET REGIONAL HEALTH-WESTERN PACIFIC,34,
MLA：
Xiao Dan,et al."National Brain Tumour Registry of China (NBTRC) statistical report of primary brain tumours diagnosed in China in years 2019-2020".LANCET REGIONAL HEALTH-WESTERN PACIFIC 34.(2023)

相关文献

[1]Chinese Clinical Trial Registry 13-year data collection and analysis: geographic distribution, financial support, research phase, duration, and disease categories [2]Rational and design of the China Pulmonary Thromboembolism Registry Study (CURES): A prospective multicenter registry [3]Distribution of Asbestos Enterprises and Asbestosis Cases - China, 1997-2019. [4]Human papillomavirus genotype distribution among HPV-positive women in Sichuan province, Southwest China. [5]Outcome of CARE: a 6-year national registry of acquired haemophilia A in China. [6]Evaluation of high-risk Human papillomaviruses type distribution in cervical cancer in Sichuan province of China [7]Distribution of Human Papillomavirus Genotypes in Archival Cervical Lesions in Eastern Inner Mongolian Autonomous Region, China [8]Treatment patterns and outcomes in Chinese gastric cancer patients by HER2 status: a non-interventional registry study (EVIDENCE). [9]Analysis of a registry database for esophageal cancer from high-volume centers in China. [10]Customizing delivery nano-vehicles for precise brain tumor therapy

资源点击量：43378 今日访问量：0 总访问量：3120 更新日期：2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号